CSL lands contract to supply Canada with 15m vaccines in the event of flu pandemic
Make us a preferred source
Make us a preferred source on Google
The news: CSL’s vaccine arm Seqirus has been awarded an advance order contract with the Public Health Agency of Canada to supply 15 million doses in the event that the World Health Organisation declares a flu pandemic.
The numbers: The 15 million doses of cell-based adjuvated pandemic influenza vaccine will be manufactured at CSL’s manufacturing facility in Tullamarine, Melbourne. The company declined to disclose the value of the contract because it is commercially sensitive.
The context: The contract has been signed as part of Canada’s pandemic preparedness plan and is the first international contract to be secured for the Tullamarine facility. Seqirus has previously been contracted to provide an egg-based influenza vaccine to Canada in the event of a pandemic.
CSL said Seqirus has a “long-term partnership with the Australian Government and is a pandemic preparedness partner to more than 30 governments around the world”.
CSL also said the Tullamarine manufacturing site supports a supply chain worth $300 million annually to the Australian economy.
The deal was announced alongside Canadian Prime Minister Mark Carney’s visit to Australia.
What they said: “The pandemic vaccine preparedness contract will help protect Canadians against future pandemic events and demonstrates how Australian and Canadian science and health collaboration is supporting our health and economic security, supply chain resilience, and pandemic preparedness,” Carney and Australian Prime Minister Anthony Albanese said in a joint statement.
The sources: CSL media release, Joint statement by Mark Carney and Anthony Albanese
